SCHEMBL13611334

SCHEMBL13611334

O=C=Nc1ccc(C(=O)OCC(=O)OCC(COC(=O)COC(=O)c2ccc(N=C=O)cc2)(COC(=O)COC(=O)c2ccc(N=C=O)cc2)COC(=O)COC(=O)c2ccc(N=C=O)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.45
HIF1A Q16665 1/20 0.45
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
PRSS1 P07477 2/20 0.35
PRSS2 P07478 2/20 0.35
PRSS3 P35030 2/20 0.35
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.33
NOS3 P29474 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14802576 0.89 MAPK1 (0.37) MAPK1HIF1ATSHRCYP3A4PRSS1
SCHEMBL12152613 0.88 MAPK1 (0.40) MAPK1HIF1ATSHRCYP3A4CYP1A2
SCHEMBL13611320 0.87 TSHR (0.41) MAPK1TSHRCYP3A4CYP1A2CYP2C9
SCHEMBL13611326 0.84 PRSS1 (0.45) MAPK1TSHRCYP3A4CYP1A2CYP2C9
SCHEMBL13611354 0.84 PRSS1 (0.47) MAPK1TSHRCYP3A4CYP1A2CYP2C9
SCHEMBL13611328 0.83 SERPINE1 (0.40) MAPK1TSHRCYP3A4PRSS1PRSS2
SCHEMBL13611329 0.83 PRSS1 (0.44) MAPK1TSHRCYP3A4CYP1A2CYP2C9
SCHEMBL2350932 0.82 ALDH1A1 (0.44) MAPK1TSHRCYP3A4NPC1RAB9A
SCHEMBL12152615 0.81 MAPK1 (0.37) MAPK1HIF1ATSHRCYP3A4CYP1A2
SCHEMBL16270514 0.81 PRSS1 (0.43) HIF1ATSHRCYP3A4CYP1A2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367747-B2 Bioabsorbable polymers from bioabsorbable polyisocyanates and uses thereof BEZWADA BIOMEDICAL, LLC (US) 2013-02-05 US disclosed
US-8367747-B2 Bioabsorbable polymers from bioabsorbable polyisocyanates and uses thereof BEZWADA BIOMEDICAL, LLC (US) 2013-02-05 US disclosed
US-20090292029-A1 BIOABSORBABLE POLYMERS FROM BIOABSORBABLE POLYISOCYANATES AND USES THEREOF BEZWADA BIOMEDICAL, L.L.C (US) 2009-11-26 US disclosed
US-20090292029-A1 BIOABSORBABLE POLYMERS FROM BIOABSORBABLE POLYISOCYANATES AND USES THEREOF BEZWADA BIOMEDICAL, L.L.C (US) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090292029-A1 BIOABSORBABLE POLYMERS FROM BIOABSORBABLE POLYISOCYANATES AND USES THEREOF PUF60, PFAS, UROD MAPK1 4264/4885HIF1A 1801/4885TSHR 4667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.